Skip to content
DefDex

Federal award

BIOMERIEUX INC

W81K0020P0036

Contract

Obligated and Ceiling

Obligated (net)
$822,015.40
Ceiling (potential value, not spending)
$822,015.40
Current value
$822,015.40
Gross positive obligations
$1,155,524.20

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
BIOMERIEUX INC · HCNVCMEG9NL6
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
BIOMERIEUX INC · HCNVCMEG9NL6
Awarding agency
Department of War · sub-agency 2100 · office W81K00
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W81K0020P0036
Award type code
B
Actions
14 · Sep 4, 2020 to Apr 19, 2024
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History14

Award actions
DateFYModAction typeObligationCompany in company totals
Apr 19, 2024FY2024P00013C−$185,796.20
—
Oct 31, 2023FY2024P00012C$335,603.48
—
Aug 7, 2023FY2023P00011C−$115,275.80
—
Jun 13, 2023FY2023P00010G$0.00
—
Oct 16, 2022FY2023P00009C$301,572.80
—
May 12, 2022FY2022P00008M$0.00
—
Apr 21, 2022FY2022P00007G$0.00
—
Jan 21, 2022FY2022P00006M$0.00
—
Oct 7, 2021FY2022P00005C$271,872.92
—
Jun 30, 2021FY2021P00004C−$32,436.80
—
Mar 26, 2021FY2021P00003G$0.00
—
Oct 29, 2020FY2021P00002C$224,500.08
—
Oct 1, 2020FY2021P00001M$0.00
—
Sep 4, 2020FY20200—$21,974.92
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.